← Eichor
Condition: Epilepsy Seizure Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Epilepsy Seizure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
EARLY_Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT07675746Genotype, Phenotype, and Disease Progression of Developmental Epileptic Encephalopathy With Onset Before 2 Years of Age
Phase N/A · 2 location(s) · Number 2 Children's Hospital, Ho Chi Minh City · NCT06278428AI-Based Mobile Intervention on Medication Non-Adherence and Transition
NA · 2 location(s) · University of Central Florida · NCT07445074Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)
Phase 4 · 3 location(s) · All India Institute of Medical Sciences, Jodhpur · NCT07072624Etiology and Treatment of Neonatal Seizure
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT03822741SeizEAR Safety Study
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07088835An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Phase 2 · 11 location(s) · Praxis Precision Medicines · NCT06908356Effect of GABA on ADHD and Seizures in Children With Epilepsy.
Phase 4 · 1 location(s) · Sherief Abd-Elsalam · NCT04144439Predisposing Factors for Post-stroke Epilepsy
Phase N/A · 1 location(s) · Norwegian University of Science and Technology · NCT05864547Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Phase 3 · 4 location(s) · Rapport Therapeutics Inc. · NCT07563881Mapping of Human Cognition
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT05989893Ear-Seizure Detection (EarSD) Study
NA · 2 location(s) · Felicia Chu · NCT06598189De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
Phase N/A · 1 location(s) · University of New Mexico · NCT05140265Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking
NA · 1 location(s) · Empatica, Inc. · NCT06275685Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution i
Phase N/A · 6 location(s) · MJN Neuroserveis, S.L · NCT05845255Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain
Phase N/A · 1 location(s) · Aziende Chimiche Riunite Angelini Francesco S.p.A · NCT06716801A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds
Phase 3 · 1 location(s) · Ono Pharmaceutical Co., Ltd. · NCT07594158A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
Phase 3 · 36 location(s) · UCB Biopharma SRL · NCT04715646Infrared Photobiomodulation in Humans With Epilepsy
NA · 1 location(s) · Beth Israel Deaconess Medical Center · NCT07145489Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Phase 3 · 5 location(s) · Rapport Therapeutics Inc. · NCT07594119Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
NA · 1 location(s) · Mayo Clinic · NCT07012148Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy
NA · 3 location(s) · Children's Hospital Medical Center, Cincinnati · NCT06608966RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Phase 2 · 1 location(s) · Supernus Pharmaceuticals, Inc. · NCT06798896Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients
NA · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04653012Retraining and Control Therapy (ReACT)- Adults
NA · 1 location(s) · University of Alabama at Birmingham · NCT06570954Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs
NA · 1 location(s) · Duke University · NCT06545643Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and
Phase 3 · 71 location(s) · SK Life Science, Inc. · NCT05219617A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Phase 3 · 95 location(s) · Xenon Pharmaceuticals Inc. · NCT05716100Improving Diagnostics and Care After First Seizure
Phase N/A · 1 location(s) · Haukeland University Hospital · NCT06814665PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06892457
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.